# Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem

> **NCT02090855** · — · COMPLETED · sponsor: **GE Healthcare** · enrollment: 108 (actual)

## Conditions studied

- Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02090855
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2017-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02090855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02090855, "Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02090855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*